ResearcherWake Forest University Health SciencesNo recent work listed

Wei Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2235-1851; OpenAlex author ID A5100441586. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 8

Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper

Papers 2

IGFBP2 promotes tumor progression by inducing alternative polarization of macrophages in pancreatic ductal adenocarcinoma through the STAT3 pathway. Last author DOI 10.1016/j.canlet.2020.12.008 ↗
Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-cen… Co-author DOI 10.1016/s1470-2045(17)30314-5 ↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Boris Pasche · 2 shared papers, 2017–2021 · strength 0.17
- Paper IGFBP2 promotes tumor progression by inducing alternative polarization of macrophages in pancreatic ductal adenocarcino… DOI 10.1016/j.canlet.2020.12.008 ↗
- Paper Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with me… DOI 10.1016/s1470-2045(17)30314-5 ↗
Longhao Sun · 1 shared paper, 2021 · strength 0.12
- Paper IGFBP2 promotes tumor progression by inducing alternative polarization of macrophages in pancreatic ductal adenocarcino… DOI 10.1016/j.canlet.2020.12.008 ↗
Liang Liu · 1 shared paper, 2021 · strength 0.12
- Paper IGFBP2 promotes tumor progression by inducing alternative polarization of macrophages in pancreatic ductal adenocarcino… DOI 10.1016/j.canlet.2020.12.008 ↗
Huamin Wang · 1 shared paper, 2021 · strength 0.12
- Paper IGFBP2 promotes tumor progression by inducing alternative polarization of macrophages in pancreatic ductal adenocarcino… DOI 10.1016/j.canlet.2020.12.008 ↗
Ya’an Kang · 1 shared paper, 2021 · strength 0.12
- Paper IGFBP2 promotes tumor progression by inducing alternative polarization of macrophages in pancreatic ductal adenocarcino… DOI 10.1016/j.canlet.2020.12.008 ↗
Jason B. Fleming · 1 shared paper, 2021 · strength 0.12
- Paper IGFBP2 promotes tumor progression by inducing alternative polarization of macrophages in pancreatic ductal adenocarcino… DOI 10.1016/j.canlet.2020.12.008 ↗
Clancy J. Clark · 1 shared paper, 2017 · strength 0.05
- Paper Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with me… DOI 10.1016/s1470-2045(17)30314-5 ↗
Angela Tatiana Alistar · 1 shared paper, 2017 · strength 0.05
- Paper Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with me… DOI 10.1016/s1470-2045(17)30314-5 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.